The Heterogeneous Cellular States of Glioblastoma Stem Cells Revealed by Single-Cell Analysis

Author:

Yan Haoteng123,Zhu Jiali1,Ping Yanyan1ORCID,Yan Min1,Liao Gaoming1,Yuan Huating4,Zhou Yao1,Xiang Fengyu1,Pang Bo1,Xu Jinyuan1,Pang Lin1ORCID

Affiliation:

1. College of Bioinformatics Science and Technology, Harbin Medical University , China

2. Advanced Innovation Center for Human Brain Protection, and National Clinical Research Center for Geriatric Disorders, Xuanwu Hospital Capital Medical University , Beijing , People’s Republic of China

3. Aging Translational Medicine Center, Xuanwu Hospital, Capital Medical University , Beijing , People’s Republic of China

4. Bioinformatics and BioMedical Bigdata Mining Laboratory, School of Big Health, Guizhou Medical University , Guiyang , People’s Republic of China

Abstract

Abstract Glioblastoma stem cells (GSCs) contributed to the progression, treatment resistance, and relapse of glioblastoma (GBM). However, current researches on GSCs were performed usually outside the human tumor microenvironment, ignoring the importance of the cellular states of primary GSCs. In this study, we leveraged single-cell transcriptome sequencing data of 6 independent GBM cohorts from public databases, and combined lineage and stemness features to identify primary GSCs. We dissected the cell states of GSCs and correlated them with the clinical outcomes of patients. As a result, we constructed a cellular hierarchy where GSCs resided at the center. In addition, we identified and characterized 2 different and recurrent GSCs subpopulations: proliferative GSCs (pGSCs) and quiescent GSCs (qGSCs). The pGSCs showed high cell cycle activity, indicating rapid cell division, while qGSCs showed a quiescent state. Then we traced the processes of tumor development by pseudo-time analysis and tumor phylogeny, and found that GSCs accumulated throughout the whole tumor development period. During the process, pGSCs mainly contributed to the early stage and qGSCs were enriched in the later stage. Finally, we constructed an 8-gene prognostic signature reflecting pGSCs activity and found that patients whose tumors were enriched for the pGSC signature had poor clinical outcomes. Our study highlights the primary GSCs heterogeneity and its correlation to tumor development and clinical outcomes, providing the potential targets for GBM treatment.

Funder

Natural Science Foundation of China

China Postdoctoral Science

Heilongjiang Postdoctoral Foundation

Publisher

Oxford University Press (OUP)

Subject

Cell Biology,Developmental Biology,Molecular Medicine

Reference67 articles.

1. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N Engl J Med.,2005

2. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma;Patel;Science.,2014

3. Identification of human brain tumour initiating cells;Singh;Nature.,2004

4. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response;Bao;Nature.,2006

5. A restricted cell population propagates glioblastoma growth after chemotherapy;Chen;Nature.,2012

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3